{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T03:07:30Z","timestamp":1770174450022,"version":"3.49.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1097\/ccm.0000000000006979","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T15:00:19Z","timestamp":1766070019000},"page":"368-371","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The Heart in Overdrive, the Mind in Doubt"],"prefix":"10.1097","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1293-8496","authenticated-orcid":false,"given":"Steven M.","family":"Hollenberg","sequence":"first","affiliation":[{"name":"Division of Cardiology, Emory University School of Medicine, Atlanta, GA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Basmaji","sequence":"additional","affiliation":[{"name":"Division of Critcal Care, Western University, London, ON, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"R1-20260203","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1097\/CCM.0000000000001078","article-title":"Beta1-adrenergic inhibition improves cardiac and vascular function in experimental septic shock.","volume":"43","author":"Kimmoun","year":"2015","journal-title":"Crit Care Med"},{"key":"R2-20260203","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/cc8026","article-title":"Bench-to-bedside review: Beta-adrenergic modulation in sepsis.","volume":"13","author":"de Montmollin","year":"2009","journal-title":"Crit Care"},{"key":"R3-20260203","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jama.2013.278477","article-title":"Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: A randomized clinical trial.","volume":"310","author":"Morelli","year":"2013","journal-title":"JAMA"},{"key":"R4-20260203","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s42077-020-00107-5","article-title":"Evaluation of the safety and efficacy of beta blockers in septic patients: A randomized control trial.","volume":"12","author":"Gadallah","year":"2020","journal-title":"Ain Shams J Anesthesiol"},{"key":"R5-20260203","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s40261-015-0325-3","article-title":"Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: A prospective, randomized trial.","volume":"35","author":"Wang","year":"2015","journal-title":"Clin Drug Investig"},{"key":"R6-20260203","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/SHK.0000000000001905","article-title":"Esmolol to treat the hemodynamic effects of septic shock: A randomized controlled trial.","volume":"57","author":"Cocchi","year":"2022","journal-title":"Shock"},{"key":"R7-20260203","first-page":"1317","article-title":"Effect of esmolol in septic shock patients with tachycardia: A randomized clinical trial.","volume":"99","author":"Liu","year":"2019","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"R8-20260203","first-page":"759","article-title":"Esmolol improves clinical outcome and tissue oxygen metabolism in patients with septic shock through controlling heart rate.","volume":"27","author":"Xinqiang","year":"2015","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"R9-20260203","first-page":"390","article-title":"Effect of esmolol on hemodynamics and clinical outcomes in patients with septic shock.","volume":"29","author":"Wang","year":"2017","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"R10-20260203","doi-asserted-by":"crossref","first-page":"e29820","DOI":"10.1097\/MD.0000000000029820","article-title":"Benefits of esmolol in adults with sepsis and septic shock: An updated meta-analysis of randomized controlled trials.","volume":"101","author":"Zhang","year":"2022","journal-title":"Medicine (Baltim)"},{"key":"R11-20260203","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/01.CIR.73.4.637","article-title":"The coronary circulation in human septic shock.","volume":"73","author":"Cunnion","year":"1986","journal-title":"Circulation"},{"key":"R12-20260203","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ajem.2019.12.007","article-title":"An emergency medicine approach to troponin elevation due to causes other than occlusion myocardial infarction.","volume":"38","author":"Long","year":"2020","journal-title":"Am J Emerg Med"},{"key":"R13-20260203","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1124\/jpet.116.232884","article-title":"Comparison of the beta-adrenergic receptor antagonists landiolol and esmolol: Receptor selectivity, partial agonism, and pharmacochaperoning actions.","volume":"359","author":"Nasrollahi-Shirazi","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"R14-20260203","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S2213-2600(20)30037-0","article-title":"Efficacy and safety of landiolol, an ultra-short-acting beta1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): A multicentre, open-label, randomised controlled trial.","volume":"8","author":"Kakihana","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R15-20260203","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1007\/s00134-024-07587-1","article-title":"Landiolol for heart rate control in patients with septic shock and persistent tachycardia. A multicenter randomized clinical trial (Landi-SEP).","volume":"50","author":"Rehberg","year":"2024","journal-title":"Intensive Care Med"},{"key":"R16-20260203","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.2023.20134","article-title":"Landiolol and organ failure in patients with septic shock: The STRESS-L randomized clinical trial.","volume":"330","author":"Whitehouse","year":"2023","journal-title":"JAMA"},{"key":"R17-20260203","doi-asserted-by":"crossref","first-page":"e1125","DOI":"10.1097\/CCM.0000000000006604","article-title":"Impact of short-acting beta-blockers on the outcomes of patients with septic shock: A systematic review and meta-analysis.","volume":"53","author":"McChesney","year":"2025","journal-title":"Crit Care Med"},{"key":"R18-20260203","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.chest.2024.08.020","article-title":"Mortality in patients with sepsis treated with esmolol or landiolol: A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis.","volume":"167","author":"Sato","year":"2025","journal-title":"Chest"},{"key":"R19-20260203","first-page":"324","article-title":"Comparison of esmolol versus landiolol on mortality in adult patients with sepsis: A systematic review and network meta-analysis.","volume":"54","author":"Tang","year":"2026","journal-title":"Crit Care Med"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006979","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T15:00:24Z","timestamp":1770130824000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000006979","relation":{},"ISSN":["0090-3493","1530-0293"],"issn-type":[{"value":"0090-3493","type":"print"},{"value":"1530-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]}}}